Articles Tagged With: COVID-19
-
Delayed Screenings Correlate with More Severe Lung Cancer Malignancies
COVID-19 led to canceled or delayed care in 2020 — with consequences.
-
Teletriage Applications Help EDs Improve Efficiency, Respond to COVID-19 Pandemic
As the demand for virtual care has accelerated, teletriage has melded well with other telemedicine innovations that may permanently change many of the ways in which emergency care is delivered. Some early adopters explain what pushed them out of the gate early, how teletriage has helped them manage the challenges posed by COVID-19, and how they see the approach evolving.
-
CDC Revises COVID-19 Quarantine Recommendations
Now, quarantine can end after 10 days without a COVID-19 test if the person has reported no symptoms, or after seven days with a negative test if the person has reported no symptoms.
-
The Work of Vaccinating Frontline Healthcare Workers Against COVID-19 Begins
Hospitals are scrambling to ensure a smooth and effective process for vaccinating frontline healthcare workers against COVID-19. Leaders need to quickly equip their personnel with enough information to persuade them that the vaccine is safe and effective.
-
Treatment of COVID-19 Patients with Remdesivir, Hydroxychloroquine, Lopinavir, or Interferon Beta-1a
None of the four drugs studied was superior to placebo.
-
Casirivimab + Imdevimab Injection
Casirivimab/imdevimab should be used to treat mild to moderate COVID-19 in adults and patients ≥ 12 years of age weighing at least 40 kg who have tested positive for SARS-CoV-2.
-
Healthcare Personnel COVID-19 Hospitalizations and Vaccine Prioritization
During the period of study, 5.9% of individuals hospitalized for COVID-19-related reasons were healthcare providers (HCP), with approximately one-third involving HCP who were not expected to directly contact patients.
-
Convalescent Plasma Therapy Does Not Affect Time to Clinical Improvement in Patients with Severe and Life-Threatening COVID-19
This was a randomized, open-label, multicenter trial of intravenous convalescent plasma infusion (4 mL/kg to 13 mL/kg) therapy. Convalescent plasma therapy was not associated with improvements in mortality or time to clinical improvement.
-
A Review of Current Therapeutics for Severe COVID-19 Pneumonia
The aim of this special feature is to review therapeutic options for hospitalized patients with COVID-19 pneumonia.
-
Novel COVID-19 Syndrome in Adults
Healthcare workers could be at risk of multisystem inflammatory syndrome linked to COVID-19, as the poorly understood condition, first seen in children, now is emerging in adults.